Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous MSCs for Postoperative Air Leak
NCT02045745Phase 2Unknown
- Sponsor
- Red de Terapia Celular
- Start
- Dec 2013
- Primary completion
- Dec 2017
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous mesenchymal stem cells in air leak syndrome (ALS), sponsored by Red de Terapia Celular. Status: unknown.
02
Drugs
autologous mesenchymal stem cells
03
Conditions
air leak syndrome (ALS)
Beyond the preview
Go deeper on NCT02045745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02045745.